Literature DB >> 10884069

Targeting of tetracycline-regulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors.

G S Ralph1, A Bienemann, T C Harding, M Hopton, J Henley, J B Uney.   

Abstract

Targeting regulatable transgene expression specifically to neuronal or glial cell populations would facilitate studies of CNS gene function. We have developed the tetracycline (Tet) regulatable adenoviral system by expressing the Tet-off transactivator (tTA) under the control of the neuronal-specific synapsin I promoter and the well characterized glial-specific glial fibrillary acidic protein (GFAP) promoter. Transfection of primary hippocampal cultures demonstrated that the respective promoters restricted reporter transgene expression exclusively to neuronal or glial populations. Delivery of the vectors into adult rat hippocampus resulted in a similar pattern of cell specific transgene expression. These novel vectors provide a highly effective means of directing regulated, cell-specific, transgene expression and as such are important tools for investigations of neuronal and glial cell function and advancing gene therapy studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884069     DOI: 10.1097/00001756-200006260-00048

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

2.  Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation.

Authors:  Kai-Christian Sonntag; Rabi Simantov; Kwang-Soo Kim; Ole Isacson
Journal:  Eur J Neurosci       Date:  2004-03       Impact factor: 3.386

3.  Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells.

Authors:  Carlos Barcia; Christian Gerdes; Wei-Dong Xiong; Clare E Thomas; Chunyan Liu; Kurt M Kroeger; Maria G Castro; Pedro R Lowenstein
Journal:  Neuron Glia Biol       Date:  2006-11

4.  Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors.

Authors:  Y Han; Q A Chang; T Virag; N C West; D George; M G Castro; M C Bohn
Journal:  Gene Ther       Date:  2010-02-18       Impact factor: 5.250

5.  Transgenic silencing of neurons in the mammalian brain by expression of the allatostatin receptor (AlstR).

Authors:  M Wehr; U Hostick; M Kyweriga; A Tan; A P Weible; H Wu; W Wu; E M Callaway; C Kentros
Journal:  J Neurophysiol       Date:  2009-08-19       Impact factor: 2.714

6.  Preferential labeling of inhibitory and excitatory cortical neurons by endogenous tropism of adeno-associated virus and lentivirus vectors.

Authors:  J L Nathanson; Y Yanagawa; K Obata; E M Callaway
Journal:  Neuroscience       Date:  2009-03-24       Impact factor: 3.590

7.  Characterization of inducible models of Tay-Sachs and related disease.

Authors:  Timothy J Sargeant; Deborah J Drage; Susan Wang; Apostolos A Apostolakis; Timothy M Cox; M Begoña Cachón-González
Journal:  PLoS Genet       Date:  2012-09-20       Impact factor: 5.917

8.  Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).

Authors:  Joanna L Howarth; Youn Bok Lee; James B Uney
Journal:  Cell Biol Toxicol       Date:  2009-10-15       Impact factor: 6.691

9.  Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain.

Authors:  Beihui Liu; Shu Wang; Michael Brenner; Julian F R Paton; Sergey Kasparov
Journal:  J Gene Med       Date:  2008-05       Impact factor: 4.565

10.  Transcriptional Targeting in Cancer Gene Therapy.

Authors:  Tracy Robson; David G. Hirst
Journal:  J Biomed Biotechnol       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.